执笔作者机构:[2]Imaging and Interventional Center, Sun Yat-Sen University Cancer Center, Guangzhou, China[3]Interventional Treatment Center, Jilin Provincial Tumor Hospital, Changchun, China[4]Department of Radiation Oncology, Peking University Third Hospital, Beijing, China[5]Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[6]Department of Interventional Therapy, Hunan Provincial Tumor Hospital, Changsha, China[7]Department of Oncology, Fuxing Hospital Affiliated to the Capital University of Medical Sciences, Beijing, China[8]Department of Interventional Therapy, Jiangsu Cancer Hospital, Nanjing, China[9]Department of Thoracic Surgery, Xuanwu Hospital Affiliated to the Capital University of Medical Sciences, Beijing, China[10]Department of Tumor Minimally Invasive Therapy, Beijing Hospital, Beijing, China[11]Interventional Treatment Center, Shandong University Second Hospital, Jinan, China[12]Division of Interventional MRI, Shandong Medical Imaging Research Institute Affiliated to Shandong University, Jinan, China[13]Department of Radiology, Chinese PLA General Hospital, Beijing, China[14]Department of Interventional Radiology, The Fourth Hospital of Harbin Medical University, Harbin, China[1]Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China[15]Department of Tumor Minimally Invasive Therapy, 307 Hospital, Beijing, China[16]Department of Minimally Invasive Interventional Therapy, Shenzhen Hospital of Beijing University, Shenzhen, China[17]Department of Interventional Therapy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China[18]Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China[19]Department of Oncology, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China[20]Department of Interventional Therapy, Beijing Cancer Hospital, Beijing, China[21]Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China[22]Department of Interventional Therapy, Tumor Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China[23]Department of Interventional Therapy, The Second Affiliated Hospital of Soochow University, Suzhou, China[24]Department of Thoracic Surgery, Shanxi Provincial Tumor Hospital, Xi'an, China[25]Tumor Interventional Therapy Center, Shanghai Renji Hospital, Shanghai, China
Although surgical resection with curative intent is the main therapy for both primary and metastatic lung tumors, about 80% of lung cancers cannot be removed by surgery. Because most patients with unresectable lung cancer only receive limited benefits from traditional radiotherapy and chemotherapy, many novel local treatment modalities have emerged including local ablation therapy. The Minimally Invasive Treatment of Lung Cancer Branch, Professional Committee of Minimally Invasive Treatment of Cancer of the Chinese Anti-Cancer Association and Committee on Tumor Ablations, Chinese College of Interventionalists have organized multidisciplinary experts to develop guidelines for this treatment modality. These guidelines aim at standardizing thermal ablation procedures, describing the indications for candidates, assessing outcomes, and preventing postablation complications.
Xin Ye,Weijun Fan,Hui Wang,et al.Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)[J].JOURNAL OF CANCER RESEARCH AND THERAPEUTICS.2018,14(4):730-744.
APA:
Xin Ye,Weijun Fan,Hui Wang,Junjie Wang,Zhongmin Wang...&Guanghui Huang.(2018).Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition).JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,14,(4)
MLA:
Xin Ye,et al."Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)".JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 14..4(2018):730-744